192 related articles for article (PubMed ID: 30295336)
1. High NEK2 confers to poor prognosis and contributes to cisplatin-based chemotherapy resistance in nasopharyngeal carcinoma.
Xu H; Zeng L; Guan Y; Feng X; Zhu Y; Lu Y; Shi C; Chen S; Xia J; Guo J; Kuang C; Li W; Jin F; Zhou W
J Cell Biochem; 2019 Mar; 120(3):3547-3558. PubMed ID: 30295336
[TBL] [Abstract][Full Text] [Related]
2. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
3. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
4. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
Yin P; Song G; Jiang Z
Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma.
Lian YF; Yuan J; Cui Q; Feng QS; Xu M; Bei JX; Zeng YX; Feng L
PLoS One; 2016; 11(3):e0152820. PubMed ID: 27030985
[TBL] [Abstract][Full Text] [Related]
6. Loss of AKR1C1 is a good prognostic factor in advanced NPC cases and increases chemosensitivity to cisplatin in NPC cells.
Zhou C; Shen G; Yang F; Duan J; Wu Z; Yang M; Liu Y; Du X; Zhang X; Xiao S
J Cell Mol Med; 2020 Jun; 24(11):6438-6447. PubMed ID: 32307891
[TBL] [Abstract][Full Text] [Related]
7. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
[TBL] [Abstract][Full Text] [Related]
8. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
[TBL] [Abstract][Full Text] [Related]
9. Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
Xia T; Tian H; Zhang K; Zhang S; Chen W; Shi S; You Y
BMC Cancer; 2021 Sep; 21(1):1003. PubMed ID: 34493236
[TBL] [Abstract][Full Text] [Related]
10. BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.
Gao W; Li JZ; Chen SQ; Chu CY; Chan JY; Wong TS
Cancer Med; 2017 Feb; 6(2):439-451. PubMed ID: 28083995
[TBL] [Abstract][Full Text] [Related]
11. Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma.
Deng CC; Liang Y; Wu MS; Feng FT; Hu WR; Chen LZ; Feng QS; Bei JX; Zeng YX
Int J Biochem Cell Biol; 2013 Sep; 45(9):1997-2006. PubMed ID: 23831840
[TBL] [Abstract][Full Text] [Related]
12. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.
Zhu Y; Hu Q; Li H
Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403
[TBL] [Abstract][Full Text] [Related]
13. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
Cui Z; Zhao Y
BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
[TBL] [Abstract][Full Text] [Related]
14. Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.
Huang PY; Zeng TT; Ban X; Li MQ; Zhang BZ; Zhu YH; Hua WF; Mai HQ; Zhang L; Guan XY; Li Y
BMC Cancer; 2016 Aug; 16(1):669. PubMed ID: 27549330
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.
Huang Y; Tian Y; Zhao Y; Xue C; Zhan J; Liu L; He X; Zhang L
Cancer Commun (Lond); 2018 May; 38(1):15. PubMed ID: 29764490
[TBL] [Abstract][Full Text] [Related]
16. CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization.
Hong X; Li Q; Li J; Chen K; He Q; Zhao Y; Liang Y; Zhao Y; Qiao H; Liu N; Ma J; Li Y
Clin Cancer Res; 2022 Oct; 28(20):4521-4535. PubMed ID: 35917517
[TBL] [Abstract][Full Text] [Related]
17. Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.
Xie P; Yang JP; Cao Y; Peng LX; Zheng LS; Sun R; Meng DF; Wang MY; Mei Y; Qiang YY; Cao L; Xiang YQ; Luo DH; Yun JP; Huang BJ; Jia LJ; Qian CN
Cell Death Dis; 2017 Jun; 8(6):e2834. PubMed ID: 28569775
[TBL] [Abstract][Full Text] [Related]
18. Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
Wu SM; Lin SL; Lee KY; Chuang HC; Feng PH; Cheng WL; Liao CJ; Chi HC; Lin YH; Tsai CY; Chen WJ; Yeh CT; Lin KH
Int J Cancer; 2017 Apr; 140(7):1581-1596. PubMed ID: 27925179
[TBL] [Abstract][Full Text] [Related]
19. BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.
Kuang CM; Fu X; Hua YJ; Shuai WD; Ye ZH; Li Y; Peng QH; Li YZ; Chen S; Qian CN; Huang W; Liu RY
Cell Death Dis; 2017 Jun; 8(6):e2874. PubMed ID: 28617432
[TBL] [Abstract][Full Text] [Related]
20. Asiatic Acid, Extracted from
Liu YT; Chuang YC; Lo YS; Lin CC; Hsi YT; Hsieh MJ; Chen MK
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 31991751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
